Global Cosmetic Grade Monoammonium Glycyrrhizinate Market Strategic Research Report
By Type: Purity ≥99%, Purity <99%
By Application: Skin Care Products, Shampoo, Tooth Paste, Mouth Washes, Other
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: VITAL-CHEM Zhuhai, Sabinsa, Alchem International, Shaanxi Fujie Pharmaceutical, MAFCO Worldwide, Alps Pharmaceutical, BGG World, Qingdao Taitong Pharmaceutical, Cokey, Jiangsu Tiansheng Pharmaceutical, Shaanxi Jintai Biological Engineering, Qinghai Lake Pharmaceutical, VITAL-CHEM Zhuhai, Shaanxi Fujie Pharmaceutical, Qingdao Taitong Pharmaceutical
Vista general
Scope of the Report
The global Cosmetic Grade Monoammonium Glycyrrhizinate market size is predicted to grow from US$ 4.69 million in 2025 to US$ 7.26 million in 2032; it is expected to grow at a CAGR of 6.6% from 2026 to 2032.
Cosmetic Grade Monoammonium Glycyrrhizinate (MAG) is a refined derivative of glycyrrhizic acid, extracted from the roots of the licorice plant (Glycyrrhiza glabra). This compound is presented as a white crystalline powder, characterized by its high purity and suitability for cosmetic applications. MAG is renowned for its potent anti-inflammatory, soothing, and skin-conditioning properties, making it a valuable ingredient in various skincare and personal care products.
In cosmetic formulations, MAG functions primarily as an anti-inflammatory agent, helping to alleviate skin irritation, redness, and discomfort. Its ability to inhibit the activity of hyaluronidase and reduce capillary permeability contributes to its effectiveness in soothing sensitive skin. Additionally, MAG exhibits antimicrobial properties, which aid in preserving the integrity of cosmetic products and protecting the skin from microbial invasion.
The compound's compatibility with other cosmetic ingredients and its stability under various formulation conditions enhance its versatility. It is commonly incorporated into products such as creams, lotions, serums, and facial masks, particularly those designed for sensitive, inflamed, or acne-prone skin. Furthermore, MAG's natural origin aligns with the growing consumer preference for plant-based and clean-label cosmetic products.
The global market for Cosmetic Grade Monoammonium Glycyrrhizinate is experiencing significant growth, driven by increasing consumer demand for natural and effective skincare solutions. The compound's multifunctional properties and its alignment with clean beauty trends position it as a sought-after ingredient in the cosmetics industry.
Key Market Drivers include:
Rising Demand for Natural Ingredients: Consumers are increasingly seeking skincare products formulated with natural and plant-derived ingredients. MAG, being sourced from licorice root, fulfills this demand, offering a natural alternative to synthetic anti-inflammatory agents.
Growth of Sensitive Skin Care Segment: The prevalence of sensitive skin conditions has led to a surge in demand for gentle and soothing skincare products. MAG's anti-inflammatory and calming properties make it an ideal ingredient for formulations targeting sensitive skin.
Expansion of Clean Beauty Movement: The clean beauty movement emphasizes transparency, safety, and sustainability in cosmetic products. MAG's natural origin and proven efficacy align with these principles, enhancing its appeal to both manufacturers and consumers.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cosmetic Grade Monoammonium Glycyrrhizinate market?
What factors are driving Cosmetic Grade Monoammonium Glycyrrhizinate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cosmetic Grade Monoammonium Glycyrrhizinate market opportunities vary by end market size?
How does Cosmetic Grade Monoammonium Glycyrrhizinate break out by Type, by Application?
This report presents a comprehensive overview of the global Cosmetic Grade Monoammonium Glycyrrhizinate market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Purity ≥99%
- Purity <99%
Segment by Application
- Skin Care Products
- Shampoo
- Tooth Paste
- Mouth Washes
- Other
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Cosmetic Grade Monoammonium Glycyrrhizinate market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Skin Care Products, Shampoo, Tooth Paste evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Cosmetic Grade Monoammonium Glycyrrhizinate Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Purity ≥99%
- 3.1.3 Purity <99%
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Skin Care Products
- 4.1.3 Shampoo
- 4.1.4 Tooth Paste
- 4.1.5 Mouth Washes
- 4.1.6 Other
- 4.1.7 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 VITAL-CHEM Zhuhai
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Sabinsa
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Alchem International
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Shaanxi Fujie Pharmaceutical
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 MAFCO Worldwide
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Alps Pharmaceutical
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 BGG World
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Qingdao Taitong Pharmaceutical
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Cokey
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Jiangsu Tiansheng Pharmaceutical
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Shaanxi Jintai Biological Engineering
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Qinghai Lake Pharmaceutical
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 VITAL-CHEM Zhuhai
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Shaanxi Fujie Pharmaceutical
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Qingdao Taitong Pharmaceutical
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Cosmetic Grade Monoammonium Glycyrrhizinate market?
What is the forecast CAGR for the Cosmetic Grade Monoammonium Glycyrrhizinate market?
What is Cosmetic Grade Monoammonium Glycyrrhizinate?
How is the Cosmetic Grade Monoammonium Glycyrrhizinate market segmented by type?
What are the key applications of Cosmetic Grade Monoammonium Glycyrrhizinate?
Which companies are profiled in the Cosmetic Grade Monoammonium Glycyrrhizinate market report?
What geographies does the Cosmetic Grade Monoammonium Glycyrrhizinate market analysis include?
What are the key demand drivers for Cosmetic Grade Monoammonium Glycyrrhizinate?
Who should buy the Cosmetic Grade Monoammonium Glycyrrhizinate market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Cosmetic Grade Monoammonium Glycyrrhizinate Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Consumer Goods & Retail